CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients

Chronic hepatitis B (CHB) infection is a serious and prevalent health concern worldwide, and the development of effective drugs and strategies to combat this disease is urgently needed. Currently, pegylated interferon-alpha (peg-IFNα) and nucleoside/nucleotide analogues (NA) are the most commonly pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Chuang, Shen, Xiaokun, Fu, Binqing, Liu, Yanyan, Chen, Yongyan, Ni, Fang, Ye, Ying, Sun, Rui, Li, Jiabin, Tian, Zhigang, Wei, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865958/
https://www.ncbi.nlm.nih.gov/pubmed/27174425
http://dx.doi.org/10.1038/srep25567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865958/
https://www.ncbi.nlm.nih.gov/pubmed/27174425
http://dx.doi.org/10.1038/srep25567

Ejemplares similares